Lv11
88 积分 2024-06-21 加入
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
25天前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
2个月前
已完结
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study
2个月前
已完结
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization
3个月前
已完结
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
3个月前
已完结
Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS, or infected by Borrelia
3个月前
已完结
The promises and challenges of neoantigen cancer vaccines
7个月前
已完结
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
11个月前
已完结
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
1年前
已完结
皖公网安备34019202002308
